Protein Peptides Market Report – Research, Industry Analysis Reports and Market Demands

Global Protein Peptides Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Protein Peptides Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Plant Protein Type (including potato, soy, pea, rice, wheat etc types)
- 1.3.3 Whey Protein Type
- 1.3.4 Casein Type
- 1.3.5 Collagen Type
- 1.3.6 Others
1.4 Market Analysis by Molecular Weight
- 1.4.1 Overview: Global Protein Peptides Consumption Value by Molecular Weight: 2021 Versus 2025 Versus 2032
- 1.4.2 Below 3,000 Da
- 1.4.3 3,000-10,000 Da
- 1.4.4 Above 10,000 Da
1.5 Market Analysis by Application
- 1.5.1 Overview: Global Protein Peptides Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Sport Nutrition
- 1.5.3 Food and Beverage
- 1.5.4 Infant Formula
- 1.5.5 Medical Nutrition
- 1.5.6 Others
1.6 Global Protein Peptides Market Size & Forecast
- 1.6.1 Global Protein Peptides Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Protein Peptides Sales Quantity (2021-2032)
- 1.6.3 Global Protein Peptides Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Protein Peptides by Manufacturer

3.1 Global Protein Peptides Sales Quantity by Manufacturer (2021-2026)
3.2 Global Protein Peptides Revenue by Manufacturer (2021-2026)
3.3 Global Protein Peptides Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Protein Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Protein Peptides Manufacturer Market Share in 2025
- 3.4.3 Top 6 Protein Peptides Manufacturer Market Share in 2025
3.5 Protein Peptides Market: Overall Company Footprint Analysis
- 3.5.1 Protein Peptides Market: Region Footprint
- 3.5.2 Protein Peptides Market: Company Product Type Footprint
- 3.5.3 Protein Peptides Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Protein Peptides Market Size by Region
- 4.1.1 Global Protein Peptides Sales Quantity by Region (2021-2032)
- 4.1.2 Global Protein Peptides Consumption Value by Region (2021-2032)
- 4.1.3 Global Protein Peptides Average Price by Region (2021-2032)
4.2 North America Protein Peptides Consumption Value (2021-2032)
4.3 Europe Protein Peptides Consumption Value (2021-2032)
4.4 Asia-Pacific Protein Peptides Consumption Value (2021-2032)
4.5 South America Protein Peptides Consumption Value (2021-2032)
4.6 Middle East & Africa Protein Peptides Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Protein Peptides Sales Quantity by Type (2021-2032)
5.2 Global Protein Peptides Consumption Value by Type (2021-2032)
5.3 Global Protein Peptides Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Protein Peptides Sales Quantity by Application (2021-2032)
6.2 Global Protein Peptides Consumption Value by Application (2021-2032)
6.3 Global Protein Peptides Average Price by Application (2021-2032)

7 North America

7.1 North America Protein Peptides Sales Quantity by Type (2021-2032)
7.2 North America Protein Peptides Sales Quantity by Application (2021-2032)
7.3 North America Protein Peptides Market Size by Country
- 7.3.1 North America Protein Peptides Sales Quantity by Country (2021-2032)
- 7.3.2 North America Protein Peptides Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Protein Peptides Sales Quantity by Type (2021-2032)
8.2 Europe Protein Peptides Sales Quantity by Application (2021-2032)
8.3 Europe Protein Peptides Market Size by Country
- 8.3.1 Europe Protein Peptides Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Protein Peptides Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Protein Peptides Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Protein Peptides Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Protein Peptides Market Size by Region
- 9.3.1 Asia-Pacific Protein Peptides Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Protein Peptides Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Protein Peptides Sales Quantity by Type (2021-2032)
10.2 South America Protein Peptides Sales Quantity by Application (2021-2032)
10.3 South America Protein Peptides Market Size by Country
- 10.3.1 South America Protein Peptides Sales Quantity by Country (2021-2032)
- 10.3.2 South America Protein Peptides Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Protein Peptides Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Protein Peptides Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Protein Peptides Market Size by Country
- 11.3.1 Middle East & Africa Protein Peptides Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Protein Peptides Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Protein Peptides Market Drivers
12.2 Protein Peptides Market Restraints
12.3 Protein Peptides Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Protein Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Protein Peptides
13.3 Protein Peptides Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Protein Peptides Typical Distributors
14.3 Protein Peptides Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Protein Peptides market size was valued at US$ 3298 million in 2025 and is forecast to a readjusted size of US$ 5149 million by 2032 with a CAGR of 6.5% during review period.
In 2025, global Protein Peptides capacity 700,000 Tons, sales reached approximately 650,000 Tons, with an average market price of around 4,930 USD/Ton, industrial gross margin 39%.
Protein peptides are best understood not as a single product category, but as a functional ingredient platform spanning collagen peptides, dairy hydrolysates, plant-derived peptides, marine peptides, and collagen-based biomaterials. Commercially, the market has moved beyond simple “high protein” positioning toward a sharper value proposition built on faster absorption, defined efficacy, superior processability, and stronger regulatory defensibility. The first tier is dominated by companies such as Rousselot, PB Leiner, GELITA, Arla Foods Ingredients, FrieslandCampina Ingredients, and Nitta Gelatin. Competition is shaped less by nominal capacity alone and more by raw material access, hydrolysis know-how, clinical substantiation, regulatory readiness, and global supply reliability.
From a technical perspective, the economics of protein peptides are driven by source material, hydrolysis route, molecular weight distribution, degree of hydrolysis, sensory control, and formulation stability. The parameters most relevant to R&D, procurement, and regulatory teams include protein content, average molecular weight and distribution, di-/tripeptide content, degree of hydrolysis, amino acid fingerprint, solubility, heat/UHT stability, bitterness, allergenicity, and microbiological performance. Collagen peptides compete on cold-water solubility, low viscosity, peptide fingerprinting, and branded efficacy positioning; dairy hydrolysates compete on low bitterness, medical and infant nutrition suitability, and the ability to remain processable even at high hydrolysis levels. The strategic shift in recent years is clear: the market is moving from generic hydrolysates toward targeted peptide systems linked to beauty, bone health, mobility, metabolic health, or performance recovery.
Application breadth is one of the most attractive features of the protein peptides sector. Upstream feedstocks include bovine and porcine hides and bones, fish skin and scales, whey streams, casein, and selected plant proteins; midstream conversion relies on pretreatment, enzymatic hydrolysis, filtration, deodorization, drying, and agglomeration; downstream demand spans nutraceuticals, functional foods, gummies, beverages, infant formula, medical nutrition, clinical nutrition, pet nutrition, capsule systems, and biomedical materials. The commercial appeal lies in a rare combination: circular-economy raw material valorization on one side and high-repeat, claims-led consumer demand on the other. The category is also widening into medical applications, where gelatin- and collagen-based systems are being positioned for tissue engineering, 3D bioprinting, and regenerative medicine.
The industry’s most consequential recent development is structural consolidation paired with functional premiumization. In 2025, Darling Ingredients and Tessenderlo Group announced and then formalized the combination of Rousselot and PB Leiner into a new company, Nextida, under an 85/15 ownership structure. Strategically, this is not merely a capacity play; it is an attempt to combine raw material access, manufacturing footprint, customer reach, and targeted peptide innovation into a more defensible global platform. In parallel, FrieslandCampina Ingredients secured EU approval for its protein hydrolysate in infant and follow-on formula, while Arla Foods Ingredients advanced higher-protein, better-tasting whey hydrolysates for peptide-based medical nutrition. These moves show where the industry is going: fewer broad commodity stories, more evidence-backed, application-specific peptide systems with higher regulatory and manufacturing barriers.
The strongest future growth drivers are unlikely to come from broader awareness of collagen alone; they will come from making protein peptides more application-ready, more clinically credible, and easier to formulate. Ready-to-drink formats, functional gummies, and convenience nutrition continue to reward low-viscosity, fast-dispersing, low-bitterness peptide systems. Joint, bone, and sports nutrition are shifting from generic protein toward targeted peptide claims. Metabolic health is emerging as a new frontier, as illustrated by Nextida GC’s GLP-1 and post-meal glucose positioning. Infant and medical nutrition continue to raise the bar on hydrolysis control, taste, compliance, and documentation. Meanwhile, biomedical collagen platforms may extend protein peptides beyond consumer health into higher-value therapeutic and regenerative domains. The strategic question is no longer who can sell peptides, but who can build a scalable, evidence-backed, regulatory-grade protein peptide platform.
This report is a detailed and comprehensive analysis for global Protein Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Protein Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Protein Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Protein Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Protein Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Protein Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Protein Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Rousselot, Tessenderlo, GELITA AG, Arla Foods Ingredients, FrieslandCampina Ingredients, Nitta Gelatin Inc, Weishardt Group, Nippi, Inc, NZMP, Carbery Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Protein Peptides market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plant Protein Type (including potato, soy, pea, rice, wheat etc types)
Whey Protein Type
Casein Type
Collagen Type
Others
Market segment by Molecular Weight
Below 3,000 Da
3,000-10,000 Da
Above 10,000 Da
Market segment by Application
Sport Nutrition
Food and Beverage
Infant Formula
Medical Nutrition
Others
Major players covered
Rousselot
Tessenderlo
GELITA AG
Arla Foods Ingredients
FrieslandCampina Ingredients
Nitta Gelatin Inc
Weishardt Group
Nippi, Inc
NZMP
Carbery Group
Agropur Ingredients
Lapi Gelatine S.p.A.
Jellice Co., Ltd
Trobas B.V.
India Gelatine & Chemicals Ltd
Gelnex
Ewald-Gelatine GmbH
Lapi Gelatine Group
Funingpu
Shandong Hengxin Biotech
Norland Products Inc
Narmada Gelatines Ltd
Hainan Huayan Collagen Technology
Zhejiang Hailisheng Biological Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Protein Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Protein Peptides, with price, sales quantity, revenue, and global market share of Protein Peptides from 2021 to 2026.
Chapter 3, the Protein Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Protein Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Protein Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Protein Peptides.
Chapter 14 and 15, to describe Protein Peptides sales channel, distributors, customers, research findings and conclusion.

Buy now